Want to see BCAB full AI Analyst Report?
Total Valuation
BioAtla has a market cap or net worth of $6.95M. The enterprise value is $8.61M.
Market Cap$6.95M
Enterprise Value$8.61M
Share Statistics
BioAtla has 1,659,554 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,659,554
Owned by Insiders27.13%
Owned by Institutions―
Financial Efficiency
BioAtla’s return on equity (ROE) is 1.65 and return on invested capital (ROIC) is 889.53%.
Return on Equity (ROE)1.65
Return on Assets (ROA)-4.31
Return on Invested Capital (ROIC)889.53%
Return on Capital Employed (ROCE)7.33
Revenue Per Employee32.79K
Profits Per Employee-977.16K
Employee Count61
Asset Turnover0.14
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioAtla is ―. BioAtla’s PEG ratio is 0.02.
PE Ratio―
PS Ratio16.70
PB Ratio-0.92
Price to Fair Value-0.92
Price to FCF-0.69
Price to Operating Cash Flow-0.17
PEG Ratio0.02
Income Statement
In the last 12 months, BioAtla had revenue of 2.00M and earned -59.61M in profits. Earnings per share was -50.50.
Revenue2.00M
Gross Profit2.00M
Operating Income-59.30M
Pretax Income-59.61M
Net Income-59.61M
EBITDA-59.23M
Earnings Per Share (EPS)-50.50
Cash Flow
In the last 12 months, operating cash flow was -37.18M and capital expenditures 0.00, giving a free cash flow of -37.18M billion.
Operating Cash Flow-37.18M
Free Cash Flow-37.18M
Free Cash Flow per Share-22.41
Dividends & Yields
BioAtla pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.94
52-Week Price Change-77.72%
50-Day Moving Average4.00
200-Day Moving Average19.27
Relative Strength Index (RSI)57.62
Average Volume (3m)40.87K
Important Dates
BioAtla upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 13, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
BioAtla as a current ratio of 0.37, with Debt / Equity ratio of -16.33%
Current Ratio0.37
Quick Ratio0.37
Debt to Market Cap0.14
Net Debt to EBITDA0.02
Interest Coverage Ratio0.00
Taxes
In the past 12 months, BioAtla has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioAtla EV to EBITDA ratio is -0.55, with an EV/FCF ratio of -0.67.
EV to Sales16.24
EV to EBITDA-0.55
EV to Free Cash Flow-0.67
EV to Operating Cash Flow-0.67
Balance Sheet
BioAtla has $1.96M in cash and marketable securities with $6.09M in debt, giving a net cash position of -$4.13M billion.
Cash & Marketable Securities$1.96M
Total Debt$6.09M
Net Cash-$4.13M
Net Cash Per Share-$2.49
Tangible Book Value Per Share-$30.76
Margins
Gross margin is 105.95%, with operating margin of -2965.25%, and net profit margin of -2980.35%.
Gross Margin105.95%
Operating Margin-2965.25%
Pretax Margin-2980.35%
Net Profit Margin-2980.35%
EBITDA Margin-2961.70%
EBIT Margin-2980.35%
Analyst Forecast
The average price target for BioAtla is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-81.82%
EPS Growth Forecast31.28%